Latest Schedule 13G passive stakes

NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.42% of Ashland Inc.'s common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.02% of Ormat Technologies Inc. common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.53% stake in Arrowhead Pharmaceuticals Inc., holding over 6.38 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 4.98% in Graphic Packaging Holding Co. as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.03% in Goodyear Tire & Rubber Co., as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 4,137,941 shares of HealthEquity Inc. common stock, representing 4.94% of the class.
NYSE
Vanguard Portfolio Management has reported a 4.9% stake in Lithia Motors Inc., holding over 1.1 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.75% in Capri Holdings Ltd, holding over 6.6 million shares.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.28% in Darling Ingredients Inc., holding over 8.39 million shares.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.21% of KB Home's common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has updated its Schedule 13G filing, reporting beneficial ownership of 4.94% of Macy's Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.38% in Harley-Davidson Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.03% of Kirby Corp's common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.91% stake in Ensign Group Inc. as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 4.97% in H&R Block Inc. common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 6.14% in Genpact Ltd, holding over 10.4 million shares.
NASDAQ
Vanguard Portfolio Management has reported beneficial ownership of 5.11% of Marzetti Company's common stock as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.05% in Knife River Corp, holding 2,870,086 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has reported a 4.38% stake in DigitalOcean Holdings Inc., holding 4,575,728 shares as of June 30, 2026.
NYSE
Vanguard Portfolio Management has filed a Schedule 13G, reporting beneficial ownership of 4.94% of Equitable Holdings Inc. common stock as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 4.97% stake in Nutanix Inc., holding over 13.4 million shares.
NASDAQ
Vanguard Portfolio Management has reported a beneficial ownership stake of 5.06% in Lantheus Holdings Inc., as of June 30, 2026.
NASDAQ
Vanguard Portfolio Management has reported a 5.31% stake in ACM Research Inc., holding over 3.4 million shares.
NASDAQ
Vanguard Capital Management has reported a 4.44% stake in Zillow Group Inc. as of June 30, 2026.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.11% of Zevra Therapeutics Inc. common stock as of June 30, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 5% of Toronto-Dominion Bank's common stock as of June 30, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 24,042,145 shares, representing 5% of Nutrien Ltd.'s common stock, as of June 30, 2026.
NASDAQ
Vanguard Capital Management has disclosed a beneficial ownership of 4.67% in Liberty Capital Corp, holding 170,728 shares.
NASDAQ
Vanguard Capital Management has reported beneficial ownership of 5.02% of Lixte Biotechnology Holdings Inc. common stock as of June 30, 2026.
NYSE
Vanguard Capital Management has reported beneficial ownership of 3,870,983 shares, representing 5.46% of Versigent PLC's common stock, as of June 30, 2026.